相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models
Thomas Wisniewski et al.
BRAIN STRUCTURE & FUNCTION (2010)
Bapineuzumab in Alzheimer's disease: where now?
Gordon K. Wilcock
LANCET NEUROLOGY (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease
A. Fernandez-Gamba et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Environmental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology
Arne Herring et al.
EXPERIMENTAL NEUROLOGY (2009)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
The Role of Apolipoprotein E in Alzheimer's Disease
Jungsu Kim et al.
NEURON (2009)
Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
Roy O Weller et al.
Alzheimers Research & Therapy (2009)
Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease
Natalia N. Nalivaeva et al.
CURRENT ALZHEIMER RESEARCH (2008)
Neprilysin and amyloid beta peptide degradation
Louis B. Hersh et al.
CURRENT ALZHEIMER RESEARCH (2008)
The role of the cell surface LRP and soluble LRP in blood-brain barrier a clearance in Alzheimer's Disease
R. Deane et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Progress in the active immunotherapeutic approach to Alzheimer's disease: Clinical investigations into AN1792-Associated meningoencephalitis
Michael Pride et al.
NEURODEGENERATIVE DISEASES (2008)
New therapeutic targets in the neurovascular pathway in Alzheimer's disease
Berislav V. Zlokovic
NEUROTHERAPEUTICS (2008)
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease
Roy O. Weller et al.
BRAIN PATHOLOGY (2008)
Developing preventive therapies for chronic diseases: Lessons learned from Alzheimer's disease
Dennis J. Selkoe
NUTRITION REVIEWS (2007)
The role of intracellular amyloid β in Alzheimer's disease
Meng Li et al.
PROGRESS IN NEUROBIOLOGY (2007)
Clearance of amyloid-β by circulating lipoprotein receptors
Abhay Sagare et al.
NATURE MEDICINE (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Apolipoprotein receptor 2 and X11 α/β mediate apolipoprotein E-induced endocytosis of amyloid-β precursor protein and β-secretase, leading to amyloid-β production
Xiangyuan He et al.
JOURNAL OF NEUROSCIENCE (2007)
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
Rashid Deane et al.
CURRENT ALZHEIMER RESEARCH (2007)
Novel modulators of amyloid-beta precursor protein processing
Bor Luen Tang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Nogo receptor interacts with brain APP and A beta to reduce pathologic changes in Alzheimer's transgenic mice
James H. Park et al.
CURRENT ALZHEIMER RESEARCH (2007)
Subcutaneous Nogo receptor removes brain amyloid-β and improves spatial memory in Alzheimer's transgenic mice
James H. Park et al.
JOURNAL OF NEUROSCIENCE (2006)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid β-peptide by the liver
Chihiro Tamaki et al.
PHARMACEUTICAL RESEARCH (2006)
Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Randall J. Bateman et al.
NATURE MEDICINE (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells:: ApoE structure as a potential therapeutic target
SM Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
JR Cirrito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The low density lipoprotein receptor-related protein (LRP) is a novel β-secretase (BACE1) substrate
CAF von Arnim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
AJ Bayer et al.
NEUROLOGY (2005)
Alzheimer disease: Mechanistic understanding predicts novel therapies
DJ Selkoe
ANNALS OF INTERNAL MEDICINE (2004)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Alzheimer's disease Aβ vaccine reduces central nervous system Aβ levels in a non-human primate, the Caribbean Vervet
CA Lemere et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches
J Tsai et al.
NATURE NEUROSCIENCE (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Targeting the Nogo receptor to treat central nervous system injuries
DHS Lee et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Peptidases, proteases and amyloid beta-peptide catabolism
LB Hersh
CURRENT PHARMACEUTICAL DESIGN (2003)
Amyloidosis and Alzheimer's disease
J Ghiso et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Aβ immunization and anti-Aβ antibodies:: potential therapies for the prevention and treatment of Alzheimer's disease
DM Holtzman et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
SCIENCE (2002)
Selective cytotoxicity of intracellular amyloid β peptide1-42 through p53 and Bax in cultured primary human neurons
Y Zhang et al.
JOURNAL OF CELL BIOLOGY (2002)
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes
DM Stern et al.
AGEING RESEARCH REVIEWS (2002)
Nasal vaccination with β-amyloid peptide for the treatment of Alzheimer's disease
CA Lemere et al.
DNA AND CELL BIOLOGY (2001)
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
J Lewis et al.
SCIENCE (2001)
β-Amyloid efflux mediated by p-glycoprotein
FC Lam et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis
SD Yan et al.
NATURE MEDICINE (2000)
Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease.: Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles
MA Colle et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)
分享论文
